Diagnostics Spectral CT Material Decomposition from Standard Single-Energy X-Ray Scans Summary This technology enables multi-material image reconstruction from conventional single-spectrum X-ray tomography data, including standard CT and tomosynthesis, without requiring dual-energy CT or photon-counting… Reference ID: 25-T-097 Desired Partnership: Co-development, Investment, Licensing IP: Patent Pending
Diagnostics Hardware Materials Medical Devices Ultrathin, Plasmonic Schottky Biointerfaces For Wireless Stimulation And Sensing A plasmon-enhanced hierarchical gold–titania (Au-TiO₂) Schottky junction biointerface designed for wireless, energy-efficient biological stimulation (neuromodulation, cardiac pacing), real-time biosensing, and minimally invasive artificial vision.… Reference ID: 25-T-190 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Medical Devices NeuroSight ICP: AI-Assisted, Real-Time Forecasting of Intracranial Pressure Crises NeuroSight ICP is a bedside-ready, AI-assisted forecasting system designed to predict intracranial pressure (ICP) crises roughly 30 minutes before onset using continuous neuro-monitoring data.… Reference ID: 26-T-074 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Medical Devices Physics-Informed Autoencoder For Non-Invasive Prediction Of Tissue Composition From MRI Data A deep learning tool that quickly and accurately estimates prostate tissue composition from MRI scans, combining physical modeling and AI to provide robust, non-invasive… Interests: Machine Learning/Artificial Intelligence Reference ID: 23-T-170 Desired Partnership: Co-development, Investment, Licensing IP: Patent Pending
Diagnostics Therapeutics Amphiregulin Screening And Inhibition Methods For Reducing Metastasis And Enhancing Radiotherapy Efficacy Methods to improve radiotherapy by blocking the protein Amphiregulin (AREG), which helps tumors resist treatment and spread. Inhibiting AREG enhances anti-tumor effects and reduces… Interests: Biomarker, Oncology Reference ID: 25-T-105 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Therapeutics A Biomarker Analysis Platform For Predicting Immunotherapy Response And Survival In Cancer Patients A method using tumor sequencing data to measure membrane-localized neoantigens, helping predict which cancer patients will benefit from immunotherapy, even those with low tumor… Interests: Biomarker, Immunotherapy, Oncology Reference ID: 22-T-017 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Medical Devices Automated Microfluidic Platform For High-Throughput 3D Cell Culture, Dynamic Stimulation, And Single-Cell Analysis Automated microfluidic platform enabling high-throughput, precise 3D cell and organoid culture, drug screening, and single-cell analysis, allowing real-time monitoring and dynamic control of cellular… Interests: Cell Line Reference ID: 18-T-053 Desired Partnership: Co-development, Licensing IP: Patent Issued
Diagnostics Research Tools Ligand-Directed Photo-Proximity Labeling Technology For Profiling And Detecting Cancer Biomarker Interactions In Live Cells Light-activated chemical probes to label and identify proteins near cancer biomarkers on live cells and tissues, enabling detailed study of protein interactions and signaling… Reference ID: 24-T-049 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Research Tools Therapeutics An Engineered Hypercompact CRISPR-Cas12f System with Boosted Gene-Editing Activity The engineered hypercompact enAsCas12f system addresses CRISPR-Cas systems deliverability issues while offering enhanced gene-editing high specificity making it ideal for therapeutic applications using AAV… Interests: Gene Therapy, Genomics Reference ID: 23-T-046 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics A Transcriptomic Signature Platform For Predicting Prognosis And Guiding Therapy In Ovarian Cancer Patients A 10-gene signature based on glucocorticoid receptor activity to predict survival risk in high-grade serous ovarian cancer patients, helping identify those who may benefit… Interests: Biomarker Reference ID: 26-T-022 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Materials Research Tools Glycan Proximity Sequencing (GPS) For Single-Cell Multi-omics Glycoproteomics TL;DR: Glycan Proximity Sequencing (GPS) is a next-generation single-cell multi-omics assay that measures mRNA expression, extracellular protein abundance, global glycan motifs, and protein-specific glycoforms… Interests: Biomarker Reference ID: 26-T-004 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Materials Research Tools Therapeutics New Reversible Uridine Modification Chemistry For Labeling and Functionalizing Native Nucleic Acids A chemical process that enables reversible, covalent RNA modification-highly selective for uridine enabling diverse functional group attachment, facilitating nucleic acid labeling The Unmet Need:… Interests: Bioinformatics, Biologics, Biomarker, Chemical Synthesis, Chemical Synthesis, Drug Delivery, Genomics, Imaging Agents, Medical, New Chemical Entity, Sequencing Reference ID: 25-T-126 Desired Partnership: Co-development, Licensing IP: Patent Pending
